The goal of 500 innovative medicines is on the horizon!

At Quality Assistance, we are committed – individually and collectively – to doing everything within our responsibilities, expertise and assigned missions to assess the quality, safety and efficacy of medicines. We provide pharmaceutical and biotech companies with the analytical support they need throughout the development process of their drug candidates. Among these medicines, we focus on the most innovative ones, those that bring added value to the Community.

In 2015, we set ourselves the challenge of contributing to the development of 500 innovative medicines and treatments by the end of 2020. Our vision and objectives remain unchanged: to accelerate the Community’s access to new medicines.

This challenge continues in 2021 and is the result of collective reflection, driven by all our colleagues across the company. It is a great source of pride for each of us to play a role in bringing tomorrow’s medicines to market.